Discontinued — last reported Q3 '24
An increase typically reflects recent strategic acquisitions of established brands or intellectual property, while a decrease may indicate divestitures or impairment write-downs. Significant changes signal shifts in the segment's competitive positioning and the value of its acquired intangible portfolio.
This metric represents the total gross book value of intangible assets within the Life Sciences segment that are determi...
Peers in the life sciences and diagnostics sectors often report this as 'Indefinite-lived Intangible Assets' or 'Trademarks and Trade Names' within their segment-level intangible asset disclosures.
dhr_segment_life_sciences_indefinite_lived_intangibles_gross_carrying_amount| Q3 '24 | |
|---|---|
| Value | $508.00M |